关注
Neil Woodford
Neil Woodford
UK Health Security Agency
在 phe.gov.uk 的电子邮件经过验证
标题
引用次数
年份
138 Use of rpoB sequence clustering for species-level identification of the Elizabethkingia genus from UK CF patients, and an investigation of associated antimicrobial …
D Kenna, A Fuller, K Martin, R Pike, C Perry, J Shah, D Lilley, R Hill, ...
Journal of Cystic Fibrosis 1 (16), S101, 2017
2017
160 Molecular profiling demonstrates clustering of Mycobacterium abscessus isolates in CF patients from a single centre
H Green, R Bright-Thomas, P Barry, A Horsley, B Isalska, N Woodford, ...
Journal of Cystic Fibrosis, S87, 2014
2014
A curated dataset of complete Enterobacteriaceae plasmids compiled from the NCBI nucleotide database
A Orlek, H Phan, AE Sheppard, M Doumith, M Ellington, T Peto, D Crook, ...
Data in brief 12, 423-426, 2017
412017
A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require …
V Decraene, HTT Phan, R George, DH Wyllie, O Akinremi, Z Aiken, ...
Antimicrobial agents and chemotherapy 62 (12), 10.1128/aac. 01689-18, 2018
131*2018
A multispecies cluster of GES-5 carbapenemase–producing Enterobacterales linked by a geographically disseminated plasmid
MJ Ellington, F Davies, E Jauneikaite, KL Hopkins, JF Turton, G Adams, ...
Clinical Infectious Diseases 71 (10), 2553-2560, 2020
282020
A Practical Guide to Clinical Bacteriology
N WOODFORD
A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK
E Taylor, AM Bal, I Balakrishnan, NM Brown, P Burns, M Clark, M Diggle, ...
Journal of Antimicrobial Chemotherapy 76 (9), 2428-2436, 2021
112021
A rapid molecular assay for the detection of antibiotic resistance determinants in causal agents of infective endocarditis
JE Moore, BC Millar, X Yongmin, N Woodford, S Vincent, CE Goldsmith, ...
Journal of applied microbiology 90 (5), 719-726, 2001
312001
A risk assessment of antibiotic pan-drug-resistance in the UK: Bayesian analysis of an expert elicitation study
D Carter, A Charlett, S Conti, JV Robotham, AP Johnson, DM Livermore, ...
Antibiotics 6 (1), 9, 2017
232017
A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with …
CG Giske, L Gezelius, Ø Samuelsen, M Warner, A Sundsfjord, ...
Clinical microbiology and infection 17 (4), 552-556, 2011
3242011
A ten-year review of Carbapenemase Producing Enterobacterales (CPE) in London, United Kingdom
B Patel, K Hopkins, D Meunier, P Staves, S Hopkins, N Woodford
Infection Control & Hospital Epidemiology 41 (S1), s6-s7, 2020
12020
A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.
MH Kabir, D Meunier, KL Hopkins, CG Giske, N Woodford
Journal of Antimicrobial Chemotherapy 71 (5), 1213-1216, 2016
552016
Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing Enterobacteriaceae
DM Livermore, S Mushtaq, M Warner, J Zhang, S Maharjan, M Doumith, ...
Antimicrobial agents and chemotherapy 55 (1), 390-394, 2011
3032011
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
DM Livermore, S Mushtaq, M Warner, JC Zhang, S Maharjan, M Doumith, ...
Journal of Antimicrobial Chemotherapy 66 (1), 48-53, 2011
3152011
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in …
DM Livermore, S Mushtaq, A Vickers, N Woodford
International Journal of Antimicrobial Agents 61 (5), 106776, 2023
152023
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance
S Mushtaq, A Vickers, N Woodford, DM Livermore
International Journal of Antimicrobial Agents 63 (3), 107081, 2024
32024
Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters
S Mushtaq, N Woodford, R Hope, R Adkin, DM Livermore
Journal of Antimicrobial Chemotherapy 68 (7), 1601-1608, 2013
452013
Activity of cefepime/zidebactam (WCK 5222) against ‘problem’antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory
S Mushtaq, P Garello, A Vickers, N Woodford, DM Livermore
Journal of Antimicrobial Chemotherapy 76 (6), 1511-1522, 2021
222021
Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015–16
DM Livermore, D Meunier, KL Hopkins, M Doumith, R Hill, R Pike, ...
Journal of Antimicrobial Chemotherapy 73 (3), 648-657, 2018
802018
Activity of ceftolozane/tazobactam against surveillance and ‘problem’ Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles
DM Livermore, S Mushtaq, D Meunier, KL Hopkins, R Hill, R Adkin, ...
Journal of Antimicrobial Chemotherapy 72 (8), 2278-2289, 2017
1252017
系统目前无法执行此操作,请稍后再试。
文章 1–20